The contraceptives market in Guatemala, specifically those based on hormones or spermicides, has witnessed a declining trend from 2013 to 2023. The market size value per capita stood at $1.33 in 2023. Year-on-year data reveals a continuous decrease over the last two years, with successive reductions of 5.96% and 5.30%. The CAGR over the past five years reflects an average annual decrease of approximately 5.43%. This trend underscores a significant shift in consumer preferences or access to contraceptive methods in the region.
Future trends to watch for include potential market stabilization or further decline driven by changes in healthcare policies, increased awareness, or alternative contraceptive methods. Monitoring consumer behavior and accessibility will be crucial for projecting future market trajectories.
